Peripheral voltage gated sodium channels in health and disease

Nerves in the skin, muscle, and internal organs are the first step in the pain pathway that ends in the brain, and researchers are now using genetically modified mice to kill specific types of these nerve cells to see what each one does. This matters because current painkillers often work too broadly, causing side effects or addiction, while many patients—especially those with chronic nerve pain—get little relief. The team has already identified a key molecule, the sodium channel Nav1.7, as a promising drug target in humans. By systematically deleting different nerve cell types in mice and observing the resulting pain behaviours, they can link specific cells to specific aspects of pain—such as the sharp sting of a cut versus the dull ache of inflammation. If this succeeds, it could lead to a new generation of painkillers that target only the nerve cells responsible for a particular type of pain, leaving other sensations intact. This would be a fundamental advance in how we treat pain, moving from blanket drugs to precision tools. The work is fundamental science—it maps the cellular wiring of pain—but it directly feeds into drug discovery pipelines that could change how millions of people manage chronic pain.